Historique
Auteur M. D. MAJEWSKA
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat à votre sélection Affiner la recherche
K. KAMPMAN ; M. D. MAJEWSKA ; TOURIAN K. ; C. DACKIS ; J. CORNISH ; S. POOLE ; C. O'BRIEN | 2003
PériodiqueENGLISH : Background : Chronic cocaine use is associated with cognitive deficits that may reduce the effectiveness of psychosocial treatment and promote relapse in newly abstinent cocaine-dependent patients. Nootropic agents, such as piracetam[...]
M. S. REID ; B. ANGRIST ; S. BAKER ; WOO C. ; M. SCHWARTZ ; A. MONTGOMERY ; M. D. MAJEWSKA ; J. ROBINSON ; J. ROTROSEN | 2005
PériodiqueENGLISH : Aims : To conduct a medication screening trial study on the efficacy of celecoxib versus placebo for the treatment of cocaine dependence. Design : A modified blinded, parallel group study in an outpatient setting using the Cocaine Ra[...]
M. S. REID ; P. CASADONTE ; S. BAKER ; SANFILIPO M. ; D. BRAUNSTEIN ; HITZEMANN A. ; A. MONTGOMERY ; M. D. MAJEWSKA ; J. ROBINSON ; J. ROTROSEN | 2005
PériodiqueENGLISH : Aims : To conduct a medication screening trial on the efficacy of olanzapine, valproate or coenzyme Q10/L-carnitine combination versus placebo for the treatment of cocaine dependence. Design : A four-arm, modified blinded, parallel g[...]
S. SHOPTAW ; W. WATSON ; C. REIBER ; R. A. RAWSON ; M. A. MONTGOMERY ; M. D. MAJEWSKA ; W. LING | 2005
PériodiqueENGLISH : Aim : This study tested three dopaminergic medications against a common unmatched placebo condition: hydergine 1 mg three times daily (n = 15); levodopa/carbidopa 25/100 mg three times daily (n = 15); cabergoline 0.5 mg per week (n =[...]
